CClinicalTrials.gg
CompletedNCT02021916LCTBUpdated Nov 10, 2021

Louisville Cooperative Tissue Biorepository

An observational study in Normal and Abnormal Tissue, sponsored by University of Louisville. Completed at 1 site in United States. Open to participants aged 7 Years and older. Per ClinicalTrials.gov, last updated 2021-11-10.

Sponsored by University of Louisville · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
17,499
Ages
7 Years and older
Sex
All
01

Study summary

To provide appropriate collection, storage, and distribution of specimens and medical data to local investigators who have approved IRB protocols for their specific research purposes.

Read the detailed description

The mission of the Louisville Cooperative Tissue Biorepository is to appropriately collect normal and abnormal tissues that are removed from the human body as a part of standard medical and surgical practice after adequate portions are secured by surgical pathologists to allow for correct diagnoses to be made. The LCTB securely stores appropriately collected human samples for research purposes and appropriately allocates these samples to local investigators for research purposes. The LCTB team appropriately documents all points in the process of obtaining informed consent, collection, storage, and allocation of tissues.

02

Conditions studied

  • Normal and Abnormal Tissue
03

In context

Lead sponsor

University of Louisville is the lead sponsor of 284 studies on the registry; 53 are open to participants now.

Of its 20 completed or terminated interventional studies of FDA-regulated products, 7 (35%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients undergoing surgery for removal of normal or abnormal tissues that are removed from the human body as part of standard medical and surgical practice at the University of Louisville Hospital, Norton Hospital downtown, Jewish Hospital downtown and Kosair Children's Hospital.

Inclusion criteria

  • Patients undergoing surgery for removal or normal and abnormal tissues as part of standard medical and surgical practice

Exclusion criteria

Exclusion Criteria:

  • Patients with known systematic infections including septic patients with bacterial and viral infections, hepatitis, HIV, TB and other defined pathogens will not be included.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
17,499 participants (actual)
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Collect normal and abnormal tissues that are removed from the human body as a part of standard surgical practice after adequate portions are secured by surgical pathologists to allow for correct diagnoses to be made.

    Time frame: 15 Years

07

Study locations

1 site
  • University of Louisville
    Louisville, Kentucky 40202, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02021916
Lead sponsor
University of Louisville
Responsible party
Robert C. Martin (Professor, University of Louisville) — Principal investigator
First posted
Dec 27, 2013
Start date
Jul 2005
Primary completion
Jan 11, 2018
Completion
Jan 11, 2018
Last update
Nov 10, 2021

Study contacts

Robert Martin, MD, PhD
principal investigator · University of Louisville

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion